Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Juniperus occidentalis pollen is a non-standardized allergenic extract derived from the pollen of the Western juniper tree. It is utilized as a biologic product for the diagnosis and treatment of immediate hypersensitivity reactions, such as allergic rhinitis and allergic asthma, specifically in patients sensitive to Western juniper. The extract is administered via intradermal, percutaneous, or subcutaneous routes. In diagnostic applications, it is used in skin testing to identify specific IgE-mediated allergies. For therapeutic purposes, it is used in allergen immunotherapy (AIT) to induce immunological tolerance by exposing the patient to gradually increasing doses of the allergen.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on juniperus occidentalis pollen.